Jonathan Leiken - 11 Aug 2023 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Reporting relationship: EVP, CLO and Secretary
Issuer ticker: DBD
Reported as of: 11 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2023, 20:53:44 UTC
Prior SEC filing: 10 Mar 2023
Next SEC filing: 01 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ Jonathan B. Leiken

Key filing fact

Jonathan Leiken filed Form 4 for DIEBOLD NIXDORF, Inc (DBD) on 11 Aug 2023.

Key facts

This page summarizes Jonathan Leiken's Form 4 filing for DIEBOLD NIXDORF, Inc (DBD).
7 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 11 Aug 2023, 20:53.

Change

Previous filing in this sequence was filed on 10 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DBD transaction

Common Shares

Other

Transaction value: $0
Shares: -249,370
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Aug 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DBD transaction Derivative

Non-Qualified Stock Option

Other

Transaction value: $0
Shares: -21,397
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Aug 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 21,397
Exercise price: $32.33
Footnotes: F1, F2

DBD transaction Derivative

Non-Qualified Stock Option

Other

Transaction value: $0
Shares: -24,581
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Aug 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 24,581
Exercise price: $27.39
Footnotes: F1, F2

DBD transaction Derivative

Non-Qualified Stock Option

Other

Transaction value: $0
Shares: -46,875
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Aug 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 46,875
Exercise price: $26.60
Footnotes: F1, F2

DBD transaction Derivative

Non-Qualified Stock Option

Other

Transaction value: $0
Shares: -24,517
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Aug 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 24,517
Exercise price: $18.75
Footnotes: F1, F3

DBD transaction Derivative

Non-Qualified Stock Option

Other

Transaction value: $0
Shares: -43,715
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Aug 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 43,715
Exercise price: $4.08
Footnotes: F1, F3

DBD transaction Derivative

Non-Qualified Stock Option

Other

Transaction value: $0
Shares: -12,048
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Aug 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 12,048
Exercise price: $11.96
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Pursuant to the Second Amended Joint Prepackaged Chapter 11 Plan of Reorganization of Diebold Holding Company, LLC and its Debtor Affiliates as revised July 7, 2023 (the "Plan of Reorganization") approved by the issuer's board of directors and confirmed by the United States Bankruptcy Court for the Southern District of Texas, all of the issuer's common shares were cancelled and extinguished on August 11, 2023, the effective date of the Plan of Reorganization, and any rights of any holder in respect thereof were cancelled without any recovery.

Footnote F2

Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.

Footnote F3

Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.